Navigation Links
European ancestry increases breast cancer risk among Latinas
Date:11/30/2008

PHILADELPHIA Latina women have a lower risk of breast cancer than European or African-American women generally, but those with higher European ancestry could be at increased risk, according to data published in the December 1 issue of Cancer Research, a journal of the American Association for Cancer Research.

"We need to study the possible factors that are placing Latina women of high European ancestry at greater risk," said Laura Fejerman, Ph.D., a post-doctoral research fellow at the University of California San Francisco. "The increased risk could be due to environmental factors, genetic factors or the interplay of the two."

Latinas are what geneticists refer to as an "admixed" population with most of their genetic ancestry from European or indigenous Americans. Fejerman said the term "indigenous Americans" usually refers to the groups that lived on the American continent prior to the arrival of the European colonizers.

For the current study, Fejerman and colleagues identified the genetic ancestry of 440 Latina women with breast cancer and 597 Latina women who did not have breast cancer.

For every 25 percent increase in European ancestry there is a 79 percent increase in the risk of breast cancer. If a woman had an estimated European ancestry of 25 percent she would be 79 percent more likely to have breast cancer than a woman of full indigenous American ancestry.

After accounting for known risk factors like number of full-term pregnancies or months of breastfeeding, the breast cancer risk for every 25 percent increase in European ancestry decreased to 39 percent, but it remained statistically significant.

Fejerman said that the overall risk of Latinas in the US is less than in European Americans but higher than indigenous Americans. She said further research would need to be conducted to determine if these differences are due to the presence of non-genetic risk factors that have not yet been described and that vary with ancestry, to the effect of genetic variants that either are protective or increase risk, or the result of the interaction between genes and non-genetic factors.


'/>"/>

Contact: Jeremy Moore
Jeremy.moore@aacr.org
267-646-0557
American Association for Cancer Research
Source:Eurekalert

Related biology news :

1. Overfishing threatens European bluefin tuna
2. European biodiversity and ecosystem scientists merge and gear up for long-term research
3. The MDS foundation supports vidazas recommendation for European approval
4. Vidaza receives positve opinion from European CHMP
5. European researchers harness unique properties of boron to develop new drugs and diagnostics
6. IronKey Opens New European Office
7. IOF calls on European citizens to stand tall and speak out for their bones
8. Major European program for the environment under the spotlight in Lille, France
9. Study helps pinpoint genetic variations in European Americans
10. European Science Foundation aims to strengthen regenerative medicine
11. European light research opens door for optical storage and computing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
(Date:4/15/2016)... 2016  A new partnership announced today will ... decisions in a fraction of the time it ... high-value life insurance policies to consumers without requiring ... Force Diagnostics, rapid testing (A1C, Cotinine and HIV) ... pressure, weight, pulse, BMI, and activity data) available ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory Compliance ... consulting, provides a free webinar on Performing Quality Investigations: Getting to ... 12pm CT at no charge. , Incomplete investigations are still a major concern ...
Breaking Biology Technology: